India to Myanmar: Warfarin Export Trade Route
India has recorded 20 verified shipments of Warfarin exported to Myanmar, representing a combined trade value of $123.2K USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $6.2K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 66% of total export value with 12 shipments worth $81.8K USD. On the buying side, JDS CO., LTD is the largest importer in Myanmar with $42.4K USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , SCOTT EDIL PHARMACIA LIMITED — together control 94% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Myanmar Warfarin corridor is one of India's established pharmaceutical export routes, with 20 shipments documented worth a combined $123.2K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's warfarin manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $6.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with warfarin's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 27.3%, placing it at rank #8 among India's top warfarin export destinations globally.
On the import side, key buyers of Indian warfarin in Myanmar include JDS CO., LTD, JDS CO LTD, JDS CO, LTD, and 7 others. JDS CO., LTD is the single largest importer with 8 shipments valued at $42.4K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ3
- Primary modeSea freight
- Top portJNPT/ NHAVA SHEVA SEA
Market Position
- Global rank#8
- Annual growth+27.3%
- Demand growth+24.8%
- Regulatory ease85/100
Top 10 Indian Warfarin Exporters to Myanmar
Showing top 10 of 6 Indian suppliers exporting Warfarin to Myanmar, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $6.8K per shipment | 12 | $81.8K | 66.4% |
| 2 | CIPLA LIMITED Avg $10.4K per shipment | 3 | $31.1K | 25.2% |
| 3 | SCOTT EDIL PHARMACIA LIMITED Avg $1.7K per shipment | 2 | $3.3K | 2.7% |
| 4 | MEHADIA TRADELINKS Avg $2.7K per shipment | 1 | $2.7K | 2.2% |
| 5 | CONICAL PHARMACEUTICALS Avg $2.3K per shipment | 1 | $2.3K | 1.9% |
| 6 | SYDLER REMEDIES PRIVATE LIMITED Avg $2.0K per shipment | 1 | $2.0K | 1.6% |
This table shows the top 10 of 6 Indian companies exporting warfarin to Myanmar, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED , SCOTT EDIL PHARMACIA LIMITED, MEHADIA TRADELINKS, CONICAL PHARMACEUTICALS, SYDLER REMEDIES PRIVATE LIMITED. CIPLA LIMITED is the dominant supplier with 12 shipments worth $81.8K USD, giving it a 66% market share. The top 3 suppliers together account for 94% of the total trade value on this route.
Top 10 Warfarin Importers in Myanmar
Showing top 10 of 10 known buyers in Myanmar receiving Warfarin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian warfarin in Myanmar include JDS CO., LTD, JDS CO LTD, JDS CO, LTD, , JDS CO, LTD , JDS CO LIMITED, among 10 total buyers. The largest importer is JDS CO., LTD, accounting for $42.4K USD across 8 shipments — representing 34% of all warfarin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | JDS CO., LTD | 8 | $42.4K | 34.4% |
| 2 | JDS CO LTD | 2 | $21.5K | 17.4% |
| 3 | JDS CO, LTD, | 1 | $16.2K | 13.2% |
| 4 | JDS CO, LTD | 2 | $14.9K | 12.1% |
| 5 | JDS CO LIMITED | 1 | $12.3K | 10.0% |
| 6 | JDS CO. LIMITED | 1 | $5.6K | 4.5% |
| 7 | TO THE DIRECTOR OF | 2 | $3.3K | 2.7% |
| 8 | TO THE MANAGER | 1 | $2.7K | 2.2% |
| 9 | TO THE ORDER OF | 1 | $2.3K | 1.9% |
| 10 | TO | 1 | $2.0K | 1.6% |
Top 10 Warfarin Formulations Imported by Myanmar
Showing top 10 of 15 product formulations shipped on the India to Myanmar Warfarin route, ranked by trade value
Myanmar imports a wide range of warfarin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — WARF - 1 TAB (WARFARIN SODIUM 1MG)(5460 PACKS X10X10S= 546000 NOS) — accounts for $19.0K USD across 1 shipments. There are 15 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | WARF - 1 TAB (WARFARIN SODIUM 1MG)(5460 PACKS X10X10S= 546000 NOS) | 1 | $19.0K | 15.5% |
| 2 | WARF - 1 TAB (WARFARIN SODIUM 1MG) (INV. | 1 | $16.2K | 13.2% |
| 3 | WARF 5 TABLETS ( WARFARIN SODIUM 5MG) ( | 2 | $14.9K | 12.1% |
| 4 | WARF 2 \WARFARIN SODIUM TABLETS USP 2 MG /MM/(10X10'SX2991PACKS= 299100 NOS) | 1 | $13.8K | 11.2% |
| 5 | WARF 2 WARFARIN SODIUM TABLETS USP 2 MG MM 10X10 S 2808 PACKx10x10 S 280800 NOS | 1 | $13.0K | 10.5% |
| 6 | Warf 2 \Warfarin sodium tablets USP 2 mg | 1 | $12.3K | 10.0% |
| 7 | WARF 2 WARFARIN SODIUM TABLETS USP 2MG MM 10X10 S 3840PACKx10X10 S 384000NUM | 1 | $8.5K | 6.9% |
| 8 | WARF - 1 TAB (WARFARIN SODIUM 1MG) (10 X 10'S X1560 Pack=156000 NOS) | 1 | $5.6K | 4.5% |
| 9 | WARF - 1 TAB (WARFARIN SODIUM 1MG)INV.QTY. 1459 PACK 10 X 10'S =145900 NOS | 3 | $5.3K | 4.3% |
| 10 | WARF - 1 TAB (WARFARIN SODIUM 1MG)INV. QTY.1170 PACK 10X10'S=117000 NOS | 3 | $4.3K | 3.5% |
Showing top 10 of 15 Warfarin formulations imported by Myanmar on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
JNPT/ NHAVA SHEVA SEA handles the highest volume with 8 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's warfarin exports to Myanmar are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 12 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , SCOTT EDIL PHARMACIA LIMITED — together account for 94% of total trade value on this route. The average shipment value of $6.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as warf - 1 tab (warfarin sodium 1mg) (inv. and warf 5 tablets ( warfarin sodium 5mg) ( , suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, JDS CO., LTD is the largest importer with 8 shipments worth $42.4K USD — representing 34% of all warfarin imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $123.2K
- Avg. Shipment
- $6.2K
- Suppliers
- 6
- Buyers
- 10
- Transit (Sea)
- ~16 days
- Annual Growth
- +27.3%
Other Warfarin Routes
Unlock the Full India to Myanmar Warfarin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 20 shipments on this route.
Frequently Asked Questions — India to Myanmar Warfarin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Warfarin to Myanmar?
The leading Indian exporters of Warfarin to Myanmar are CIPLA LIMITED, CIPLA LIMITED , SCOTT EDIL PHARMACIA LIMITED. CIPLA LIMITED holds the largest market share at approximately 66% of total trade value on this route.
Q What is the total value of Warfarin exports from India to Myanmar?
India exports Warfarin to Myanmar worth approximately $123.2K USD across 20 recorded shipments. The average value per shipment is $6.2K USD.
Q Which ports does India use to ship Warfarin to Myanmar?
The most active port of origin is JNPT/ NHAVA SHEVA SEA with 8 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Myanmar for Warfarin?
The average transit time for Warfarin shipments from India to Myanmar is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Myanmar Warfarin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.3% with demand growth tracking at 24.8%. The route is ranked #8 among India's top Warfarin export destinations globally.
Q How many suppliers are active on the India to Myanmar Warfarin route?
There are currently 6 active Indian suppliers exporting Warfarin to Myanmar. The market is moderately concentrated with CIPLA LIMITED accounting for 66% of total shipment value.
Q Who are the main importers of Warfarin from India in Myanmar?
The leading importers of Indian Warfarin in Myanmar include JDS CO., LTD, JDS CO LTD, JDS CO, LTD, , JDS CO, LTD , JDS CO LIMITED. JDS CO., LTD is the largest buyer with 8 shipments worth $42.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Myanmar export trade corridor identified from Indian Customs (DGFT) records for Warfarin.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 10 importers in Myanmar matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 20 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
20 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists